IMPORTANT NOTE. We strongly recommend that you consult your doctor for proper advice before using any medications, including vitamins, supplements, herbals and products for the skin.
Brand Name, Dosage Format and Strength
Asmalin Broncho 1 mg/ 50 mg per 5 mL Syrup
Corticosteroid, Anticholinergic, Beta2-Agonist, Leukotriene Inhibitor, Beta2-Agonist, Beta2-Agonist, Expectorant, Antiasthma-Beta2- Agonist, Mucolytic, Beta2-Agonist, Mucolytic, Antitussive, Nasal Decongestant, Analgesic-Antipyretic, Antitussive, Nasal Decongestant, Analgesic-Antipyretic, Nasal Decongestant, Antihistamine, Nasal Decongestant, Antihistamine, Analgesic-Antipyretic, Nasal Decongestant, Analgesic-Antipyretic, Alpha Adrenergic Agonist, Nasal Decongestant, Antihistamine, Analgesic-Antipyretic
WARNINGS AND PRECAUTIONS
If a previously effective dose fails to provide the usual relief or the usual duration of effect is reduced, consult a physician for medical advice as this may be a sign of worsening of asthma that would require reassessment of therapy.
Paradoxical bronchospasm, a potentially life-threatening event, may occur with the administration of oral Salbutamol. If it occurs, discontinue use of the product immediately.
Use with caution in acute severe asthma where concomitant therapy with steroids, xanthine derivatives, or diuretics, and by hypoxia may result in hypokalemia; plasma potassium concentrations should be monitored in severe asthma.
Therapy with salbutamol and other beta2-agonists may produce decreases in plasma potassium concentration possibly through intracellular shunting resulting in cardiovascular adverse effects.
Guaifenesin should not be used for persistent or chronic cough or when coughing is accompanied by excessive secretions unless directed by a physician. A persistent cough may be a sign of a serious condition. If cough persists for more than one week, tends to recur, or is accompanied by fever, rash, or persistent headache, consult a physician.
Use with caution in patients with the following conditions:
- Cardiovascular disorders including coronary insufficiency, cardiac arrhythmias or HTN
- Convulsive disorders
- Diabetes mellitus
- In patients who are unusually responsive to sympathomimetic amines